ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 132313 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 132313; 2) Community: the network communities that were significantly associated with the response to NSC 132313; 3) Molecule: the relationships between components within communities and NSC 132313; 4) MDR: the compounds that were significantly associated with the NSC 132313.

NSC Compound Enrichment Correlation
NSC 659687 6H-Pyrido[4,3-b]carbazole-1-carboxamide, 9-hydroxy- 5,6-dimethyl-N-[2-(dimethylamino)ethyl]-, dihydrochloride 0.000184748296800008 0.77142407
NSC 697726 RH1 0.000184748296800008 0.66703144
NSC 736611 Null 0.000184748296800008 0.46984361
NSC 758359 N3-[1-(3-phenoxybenzyl)-1H-1,2,3-triazol-4-yl]methyl-2-(4-fluoroanilino)nicotinamide 0.000184748296800008 -0.035961887
NSC 683247 Acridine-4-carboxamide, 9-amino-5-methyl- N-[2-(dimethylamino)ethyl]-, dihydrochloride 0.000192047964657656 0.61325535
NSC 275656 m-Dioxane-5-methanol, 2,2-dimethyl-5-(4,6-diaziridinyl-2-S-triazinylamino)- 0.000216242727122389 0.93371793
NSC 606172 Camptothecin Derivative 0.000216242727122389 0.80045049
NSC 606985 Camptothecin Derivative 0.000216242727122389 0.75195964
NSC 646127 6H-Pyrido[4,3-b]carbazole, 1,2-dihydro-2,5,9,11-tetra- methyl- 0.000216242727122389 -0.0351273
NSC 659949 14-Bromo-7-O-(2,3,6-trideoxy-2-fluoro-.alpha.-L-talo-hexo- pyranosyl)-4-demethoxydaunomycinone 0.000216242727122389 0.71031869
Total:90  Current:2    [First] [Prev] [Next] [Last]